- HK$11.02bn
- HK$44.29bn
- CNY47.54bn
- 30
- 52
- 47
- 38
Annual balance sheet for China Risun, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | Interim Report | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,190 | 2,371 | 1,444 | 1,239 | 2,239 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,951 | 4,186 | 5,239 | 6,234 | 13,524 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 7,203 | 12,147 | 13,389 | 17,134 | 21,103 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 12,417 | 18,383 | 24,158 | 29,115 | 29,513 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 24,461 | 36,782 | 46,103 | 53,836 | 59,841 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 13,190 | 16,841 | 25,047 | 29,955 | 33,796 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 16,222 | 25,814 | 33,992 | 40,938 | 47,081 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 8,239 | 10,968 | 12,110 | 12,898 | 12,760 |
Total Liabilities & Shareholders' Equity | 24,461 | 36,782 | 46,103 | 53,836 | 59,841 |
Total Common Shares Outstanding |